🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

112 results for “alcohol” Clear

  1. Alcohol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    phase 1 small molecule completed

    1 trial

  2. Alcohol

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Drinking

    phase 1 small molecule completed

    1 trial

  3. Alcohol + Caffeine Beverage

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol or Other Drugs Effects

    phase 1 small molecule completed

    1 trial

  4. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Naltrexone hydrochloride film-coated tablet, 50 mg, manufactured by Sun Pharmaceutical Industries Limited, India with NALTREXONE GH (naltrexone hydrochloride) film-coated tablets 50 mg, Product of Generic Health Pty Ltd Suite 2, Level 2 19-23 Prospect Street Box Hill, VIC, 3128, Australia, in healthy adult, human subjects under fasting condition.

    Pharma Mar S.A.

    Alcohol dependence

    phase 1 other active

    1 trial

  5. Anti-human CCL24 monoclonal antibody (CM-101) - Part One

    Chemomab Therapeutics

    Nonalcoholic Fatty Liver Disease

    phase 1 small molecule completed

    1 trial

  6. CM-101

    Chemomab Therapeutics

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  7. Chinese tea flavor liquor

    China SXT Pharmaceuticals

    Alcohols

    phase 1 other completed

    1 trial

  8. Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg

    BioXcel Therapeutics

    Alcohol Use Disorder (AUD)

    phase 1 small molecule active

    1 trial

  9. EDP-297

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis

    phase 1 small molecule completed

    1 trial

  10. EDP-305

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    2 trials

  11. Evaluate the effects of Environmental Enrichment (EE) on alcohol consumption

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 1 other active

    1 trial

  12. Fluconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  13. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Non-Alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  14. HEC169584 capsule

    Sunshine Biopharma

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  15. HEC96719

    Sunshine Biopharma

    Non-alcoholic Fatty Liver Disease

    phase 1 small molecule completed

    1 trial

  16. HEC96719

    Sunshine Biopharma

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  17. HEC96719 tablets

    Sunshine Biopharma

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  18. MK-7480 Multiple Ascending Dose Study in Healthy Participants

    Merck Sharp and Dohme

    Non-alcoholic steatohepatitis

    phase 1 other active

    1 trial

  19. Minocycline

    United Therapeutics Europe Ltd

    Alcohol Dependence

    phase 1 small molecule completed

    1 trial

  20. Miricorilant

    CORCEPT THERAPEUTICS INC

    Non-alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  21. Miricorilant 150 mg

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  22. Placebo

    BioXcel Therapeutics

    Alcohol Use Disorder (AUD)

    phase 1 small molecule completed

    1 trial

  23. Randomised, relative bioavailability clinical trial of amylmetacresol, dichlorobenzyl alcohol, lidocaine and vitamin c lozenges after a single oral dose administration to healthy volunteers under fasting conditions in a crossover design.

    Pharma Mar S.A.

    healthy volunteer

    phase 1 other active

    1 trial

  24. Spironolactone

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources